Effects of surgery and topical medication on eosinophilic granulomatosis with polyangiitis with otitis media and sinusitis: a case report.
Zijing Wang,Lin Han,Lisheng Yu +2 more
TL;DR: A case of EGPA with refractory otitis media and chronic sinusitis, which were resistant to systemic high-dose steroids and immunosuppressants, which responded well to functional endoscopic sinus surgery and myringotomy and grommet insertion.
read more
Abstract: Eosinophilic granulomatosis with polyangiitis (EGPA), also known as Churg-Strauss syndrome, is eosinophil-rich, necrotizing granulomatous inflammation often involving the respiratory tract. Furthermore, EGPA is necrotizing vasculitis that predominantly affects small to medium vessels and is associated with asthma and eosinophilia. Most patients with EGPA have sinusitis and some complain of hearing loss and refractory otitis media with effusion. Systemic use of immunosuppressants and glucocorticoids is currently recommended, despite the inevitable associated side effects. However, systemic treatment is not always effective for nasal and ear symptoms. We report a case of EGPA with refractory otitis media and chronic sinusitis, which were resistant to systemic high-dose steroids and immunosuppressants. However, these symptoms responded well to functional endoscopic sinus surgery and myringotomy and grommet insertion. We also administered budesonide nasal irrigation and glucocorticoid injection by intratympanic and postaural methods in this patient. The therapeutic effect was satisfactory.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Combination Biologic Therapy with Mepolizumab and Dupilumab for Severe Eosinophilic Granulomatosis with Polyangiitis and Chronic Rhinosinusitis with Nasal Polyp
Naoki Kikumoto,Hiromi Takeuchi,Toru Kimura,Motoki Nakamori,Kazunori Fujiwara +4 more
TL;DR: A 55-year-old female with eosinophilic granulomatosis and chronic rhinosinusitis showed refractory symptoms despite conventional treatment. Switching to dupilumab improved chronic rhinosinusitis, and symptoms gradually subsided after 19 months, allowing for dupilumab discontinuation.
1
Aural Manifestations of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis—Diagnosis, Symptoms, Treatment
Michał S. Kaczmarczyk,Dariusz Jurkiewicz,Stanisław Niemczyk,Aleksandra Rymarz +3 more
TL;DR: The goal of this publication is to sum up and underline the problem of the aural manifestation of AAV; it details the definition of Otitis Media with Antineutrophil Cytoplasmic Antibody Associated Vasculitis (OMAAV) and allows for a better understanding of the specific tasks of medical professionals taking part in the diagnostic and therapeutic process.
Otologic Manifestations of Eosinophilic Granulomatosis With Polyangiitis: A Systematic Review.
Peter E. Ashman,Tiffany Chen,Gregory L. Barinsky,Brian E. Benson,Seilesh Babu,Dennis I. Bojrab,Peter F. Svider +6 more
TL;DR: In this paper, a systematic review of the diagnosis, treatment, and management of patients with eosinophilic granulomatosis with polyangiitis was performed.
References
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
John Charles Jennette,Ronald Falk,P. A. Bacon,Neil Basu,Maria C. Cid,Franco Ferrario,Luis Felipe Flores-Suárez,W. L. Gross,Loïc Guillevin,E. C. Hagen,Gary S. Hoffman,David Jayne,Cees G. M. Kallenberg,Peter Lamprecht,Carol A. Langford,Raashid Luqmani,Alfred Mahr,Eric L. Matteson,Peter A. Merkel,Peter A. Merkel,Seza Ozen,Charles D. Pusey,Niels Rasmussen,Andrew J. Rees,David G. I. Scott,Ulrich Specks,John H. Stone,Kei Takahashi,Richard A. Watts +28 more
TL;DR: 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides J. Watts; Arthritis & Rheumatism
5.7K
2012 Revised International Chapel Hill Consensus Conference Nomenclature of
John Charles Jennette,Ronald Falk,Neil Basu,Maria C. Cid,Franco Ferrario,Luis Felipe Flores-Suárez,W. L. Gross,Loïc Guillevin,E. C. Hagen,Peter Lamprecht,Raashid Luqmani,Seza Ozen,Andrew J. Rees,Scott Dgi,Ulrich Specks,Kei Takahashi,Richard A. Watts +16 more
- 01 Jan 2012
TL;DR: In this article, the running head is assigned to one of the following candidates:Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Ferrardo F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CGM, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees
2.7K
The American College of Rheumatology 1990 criteria for the classification of churg‐strauss syndrome (allergic granulomatosis and angiitis)
Alfonse T. Masi,Alfonse T. Masi,Gene G. Hunder,Gene G. Hunder,J. T. Lie,J. T. Lie,Beat A. Michel,Daniel A. Bloch,Daniel A. Bloch,William P. Arend,William P. Arend,Leonard H. Calabrese,Leonard H. Calabrese,Steven M. Edworthy,Steven M. Edworthy,Anthony S. Fauci,Anthony S. Fauci,Randi Y. Leavitt,Randi Y. Leavitt,Robert W. Lightfoot,Robert W. Lightfoot,Dennis J. McShane,Dennis J. McShane,John A. Mills,John A. Mills,Mary Betty Stevens,Mary Betty Stevens,Stanley L. Wallace,Nathan J. Zvaifler,Nathan J. Zvaifler +29 more
TL;DR: Criteria for the classification of Churg-Strauss syndrome were developed by comparing 20 patients who had this diagnosis with 787 control patients with other forms of vasculitis, and advantages of the traditional format compared with the classification tree format are discussed.
2.2K
•Journal Article
Allergic Granulomatosis, Allergic Angiitis, and Periarteritis Nodosa
Jacob Churg,Lotte Strauss +1 more
1.7K
Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients.
Loïc Guillevin,François Lhote,M. Gayraud,Pascal Cohen,Bernard Jarrousse,Olivier Lortholary,Nadine Thibult,Philippe Casassus +7 more
TL;DR: It is concluded that an initial assessment of PAN or CSS severity enables outcome and mortality to be predicted and the FFS is a good predictor of death and can be used to help the clinician choose the most adequate treatment.
979